ClinicalTrials.gov
public full text
Public Domain
Lessening Organ Dysfunction With VITamin C
LOVIT is a multicentre concealed-allocation parallel-group blinded randomized controlled trial to ascertain the effect of high-dose intravenous vitamin C compared to placebo on mortality or persistent organ dysfunction at 28 days in septic intensive care unit patients. Patients with COVID-19 are considered eligible for this study.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Outcome of High Dose Vitamin D on Prognosis of Sepsis Requiring Mechanical Ventilation#886021
- Study on the Improvement of Microcirculation in Patients With Sepsis by Vitamin B6, Vitamin B12 and Vitamin C#909524
- Blessing or Curse? Combined Vitamin Therapy in Non Viral Septic Shock.#1102631
- Vitamin D3 Supplementation in Critically Ill Patients Undergoing CRRT#1127607
- High Dose Intravenous Ascorbic Acid in Severe Sepsis#1102562
Record · ID 1127861
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive